Accueil

@article{DeCock2025,

title = {Establishment of patient-derived 3D in vitro models of sarcomas: literature review and guidelines on behalf of the FORTRESS working group},

author = {Lore De Cock and Ieva Palubeckaitė and Francesca Bersani and Tobias Faehling and Sandro Pasquali and Sam Umbaugh and Michael Torsten Meister and Molly R. Danks and Piotr Manasterski and Richard Miallot and Manuela Krumbholz and Siyer Roohani and Dominique Heymann and Florencia Cidre-Aranaz and Agnieszka Wozniak and Patrick Schöffski and Judith V.M.G. Bovée and Alessandra Merlini and Sanne Venneker},

doi = {10.1016/j.neo.2025.101171},

issn = {1476-5586},

year  = {2025},

date = {2025-07-00},

urldate = {2025-07-00},

journal = {Neoplasia},

volume = {65},

publisher = {Elsevier BV},

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{nokey,

title = {Non-cyanobacterial diazotrophs support the survival of marine microalgae in nitrogen-depleted environment },

author = {Udita Chandola and Marinna Gaudin and Camille Trottier and Louis-Josselin Lavier-Aydat and Eric Manirakiza and Samuel Menicot and Erik Jörg Fischer and Isabelle Louvet and Thomas Lacour and Timothée Chaumier and Atsuko Tanaka and Georg Pohnert and Samuel Chaffron and Leïla Tirichine},

doi = {10.1186/s13059-025-03597-4},

year  = {2025},

date = {2025-05-15},

urldate = {2025-05-15},

journal = {Genome Biology},

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{nokey,

title = {Glutamate Methylation, a Novel Histone Mark in Diatoms: Mass Spectrometry Identification and Structural Characterization},

author = {Stéphane Téletchéa and Bérangère Lombard an Johann Hendrickx and Damarys Loew and Leïla Tirichine},

doi = {10.1002/pld3.70051},

year  = {2025},

date = {2025-05-13},

urldate = {2025-05-13},

journal = {Plant Direct},

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{Heymann2025,

title = {A new promising anticancer agent: A glycosaminoglycan-mimetic derived from the marine bacterial infernan exopolysaccharide},

author = {Dominique Heymann and Javier Muñoz-Garcia and Antoine Babuty and Antoine Audéon and Emilie Ollivier and Dulce Papy-Garcia and Sandrine Chantepie and Agata Zykwinska and Corinne Sinquin and Sylvia Colliec-Jouault},

doi = {10.1016/j.ijbiomac.2025.142074},

issn = {0141-8130},

year  = {2025},

date = {2025-05-00},

urldate = {2025-05-00},

journal = {International Journal of Biological Macromolecules},

volume = {308},

publisher = {Elsevier BV},

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{Yadav2025,

title = {Circulating tumor cell markers for early detection and drug resistance assessment through liquid biopsy},

author = {Priya Yadav and Saravanan Rajendrasozhan and Ramzi Hadj Lajimi and Raja Ramadevi Patel and Dominique Heymann and N. Rajendra Prasad},

doi = {10.3389/fonc.2025.1494723},

issn = {2234-943X},

year  = {2025},

date = {2025-04-07},

urldate = {2025-04-07},

journal = {Front. Oncol.},

volume = {15},

publisher = {Frontiers Media SA},

abstract = {<jats:p>Circulating tumor cells (CTCs) are cancerous cells that extravasate from the primary tumor or metastatic foci and travel through the bloodstream to distant organs. CTCs provide crucial insights into cancer metastasis, the evolution of tumor genotypes during treatment, and the development of chemo- and/or radio-resistance during disease progression. The process of Epithelial-to-mesenchymal transition (EMT) plays a key role in CTCs formation, as this process enhances cell’s migration properties and is often associated with increased invasiveness thereby leading to chemotherapy resistance. During the EMT process, tumor cells lose epithelial markers like EpCAM and acquire mesenchymal markers such as vimentin driven by transcription factors like Snail and Twist. CTCs are typically identified using specific cell surface markers, which vary depending on the cancer type. Common markers include EpCAM, used for epithelial cancers; CD44 and CD24, which are associated with cancer stem cells; and cytokeratins, such as CK8 and CK18. Other markers like HER2/neu and vimentin can also be used to target CTCs in specific cancer types and stages. Commonly, immune-based isolation techniques are being implemented for the isolation and enrichment of CTCs. This review emphasizes the clinical relevance of CTCs, particularly in understanding drug resistance mechanisms, and underscores the importance of EMT-derived CTCs in multidrug resistance (MDR). Moreover, the review also discusses CTCs-specific surface markers that are crucial for their isolation and enrichment. Ultimately, the EMT-specific markers found in CTCs could provide significant information to halt the disease progression and enable personalized therapies.</jats:p>},

keywords = {},

pubstate = {published},

tppubtype = {article}

}